Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Jiangsu Hengrui Medicine received FDA approval to begin...
American Oriental Bioengineering (广西博科药业) is...
In the ChinaBio® Executive Workshop,...
China Aoxing Pharmaceutical Company received SFDA...
American Oriental Bioengineering...
PPD, Inc. will acquire BioDuro, a preclinical CRO, as a...
China Aoxing Pharmaceutical Company has completed its...
China Aoxing Pharmaceutical Company (中国奥星药业)...
Aoxing Pharmaceutical has been given SFDA approval to...
Aoxing Pharma reported its JV, which will produce...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
